Back
Top 8%
15.6%
Top 0.3%
15.6%
Top 0.4%
11.7%
#1
9.6%
Top 64%
8.3%
Top 0.6%
6.9%
Top 26%
4.1%
Top 8%
2.1%
Top 85%
1.7%
Top 10%
1.7%
Top 3%
1.4%
Top 25%
1.1%
Top 16%
1.0%
Top 2%
1.0%
Top 13%
1.0%
Top 3%
1.0%
Top 2%
0.8%
Top 13%
0.8%
Top 27%
0.5%
Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study
2020-04-10
rheumatology
Title + abstract only
View on medRxiv
Show abstract
BackgroundHydroxychloroquine has recently received Emergency Use Authorization by the FDA and is currently prescribed in combination with azithromycin for COVID-19 pneumonia. We studied the safety of hydroxychloroquine, alone and in combination with azithromycin. MethodsNew user cohort studies were conducted including 16 severe adverse events (SAEs). Rheumatoid arthritis patients aged 18+ and initiating hydroxychloroquine were compared to those initiating sulfasalazine and followed up over 30 d...
Predicted journal destinations
1
BMJ Open
553 training papers
2
Rheumatology
21 training papers
3
Annals of the Rheumatic Diseases
23 training papers
4
The Lancet Respiratory Medicine
16 training papers
5
PLOS ONE
1737 training papers
6
Arthritis & Rheumatology
21 training papers
7
Nature Communications
483 training papers
8
JAMA Network Open
125 training papers
9
Scientific Reports
701 training papers
10
Frontiers in Medicine
99 training papers
11
BMJ
49 training papers
12
BMC Medicine
155 training papers
13
PLOS Medicine
95 training papers
14
Journal of Clinical Epidemiology
29 training papers
15
Open Forum Infectious Diseases
124 training papers
16
New England Journal of Medicine
49 training papers
17
British Journal of General Practice
22 training papers
18
Vaccines
131 training papers
19
Journal of Clinical Medicine
77 training papers